treposa 10 mg/ml infuusioneste, liuos
amomed pharma gmbh - treprostinil sodium - infuusioneste, liuos - 10 mg/ml - treprostiniili
remodulin 1 mg/ml infuusioneste, liuos
ferrer international, sa - treprostinil sodium - infuusioneste, liuos - 1 mg/ml - treprostiniili
remodulin 10 mg/ml infuusioneste, liuos
ferrer international, sa - treprostinil sodium - infuusioneste, liuos - 10 mg/ml - treprostiniili
remodulin 2.5 mg/ml infuusioneste, liuos
ferrer international, sa - treprostinil sodium - infuusioneste, liuos - 2.5 mg/ml - treprostiniili
remodulin 5 mg/ml infuusioneste, liuos
ferrer international, sa - treprostinil sodium - infuusioneste, liuos - 5 mg/ml - treprostiniili
latanoprost/timolol stada 50 mikrog/ml + 5 mg/ml silmätipat, liuos
stada arzneimittel ag - timololi maleas,latanoprostum - silmätipat, liuos - 50 mikrog/ml + 5 mg/ml - timololi, yhdistelmävalmisteet
pro-epanutin 75 mg/ml infuusiokonsentraatti, liuosta varten/injektioneste, liuos
pfizer oy - fosphenytoin disodium heptahydrate - infuusiokonsentraatti, liuosta varten/injektioneste, liuos - 75 mg/ml - fosfenytoiini
fredomat 40 mikrog/ml silmätipat, liuos
stada arzneimittel ag stada arzneimittel ag - travoprostum - silmätipat, liuos - 40 mikrog/ml - travoprosti
ximluci
stada arzneimittel ag - ranibitsumabi - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - silmätautien - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
seroquel prolong 50 mg depottabletti
astrazeneca oy - quetiapine fumarate - depottabletti - 50 mg - ketiapiini